Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung

BACKGROUND: Little is known regarding the efficacy of immune checkpoint inhibitors (ICI) in patients with advanced large-cell neuroendocrine lung carcinoma (aLCNEC). METHODS: 125 consecutive patients with aLCNEC were identified in the electronic databases of 4 participating cancer centers. The patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Dudnik, Elizabeth, Kareff, Samuel, Moskovitz, Mor, Kim, Chul, Liu, Stephen V, Lobachov, Anastasiya, Gottfried, Teodor, Urban, Damien, Zer, Alona, Rotem, Ofer, Onn, Amir, Wollner, Mira, Bar, Jair
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Clinical/Translational Cancer Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7893659/
https://ncbi.nlm.nih.gov/pubmed/33597218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001999
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados